The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
BMC Infectious Diseases (2020) - Comments
doi: 10.1186/s12879-020-05507-4  issn: 1471-2334  pubmed: 33087047 

Naser Gharebaghi, Rahim Nejadrahim, Seyed Jalil Mousavi, Seyyed-Reza Sadat-Ebrahimi, Reza Hajizadeh